Efficacy and safety of IV/PO moxifloxacin and IV piperacillin/tazobactam followed by PO amoxicillin/clavulanic acid in the treatment of diabetic foot infections: results of the RELIEF study

N. C. Schaper; M. Dryden; P. Kujath; D. Nathwani; P. Arvis; P. Reimnitz; J. Alder; I. C. Gyssens

doi:10.1007/s15010-012-0367-x

Efficacy and safety of IV/PO moxifloxacin and IV piperacillin/tazobactam followed by PO amoxicillin/clavulanic acid in the treatment of diabetic foot infections: results of the RELIEF study

N. C. Schaper^*, M. Dryden, P. Kujath, D. Nathwani, P. Arvis, P. Reimnitz, J. Alder, I. C. Gyssens

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	175-186
Journal	Infection
Volume	41
Issue number	1
DOIs	https://doi.org/10.1007/s15010-012-0367-x
Publication status	Published - Feb 2013

Keywords

Antibiotic therapy
Diabetic foot infection
Fluoroquinolone
Moxifloxacin
Controlled clinical trial
Sequential therapy
Diabetic foot ulcer

Access to Document

10.1007/s15010-012-0367-x

Cite this

Schaper, N. C., Dryden, M., Kujath, P., Nathwani, D., Arvis, P., Reimnitz, P., Alder, J., & Gyssens, I. C. (2013). Efficacy and safety of IV/PO moxifloxacin and IV piperacillin/tazobactam followed by PO amoxicillin/clavulanic acid in the treatment of diabetic foot infections: results of the RELIEF study. Infection, 41(1), 175-186. https://doi.org/10.1007/s15010-012-0367-x

@article{75720f3a301a43b18c4fc6b7ff0f3614,

title = "Efficacy and safety of IV/PO moxifloxacin and IV piperacillin/tazobactam followed by PO amoxicillin/clavulanic acid in the treatment of diabetic foot infections: results of the RELIEF study",

keywords = "Antibiotic therapy, Diabetic foot infection, Fluoroquinolone, Moxifloxacin, Controlled clinical trial, Sequential therapy, Diabetic foot ulcer",

author = "Schaper, {N. C.} and M. Dryden and P. Kujath and D. Nathwani and P. Arvis and P. Reimnitz and J. Alder and Gyssens, {I. C.}",

year = "2013",

month = feb,

doi = "10.1007/s15010-012-0367-x",

language = "English",

volume = "41",

pages = "175--186",

journal = "Infection",

issn = "0300-8126",

publisher = "Springer",

number = "1",

}

Schaper, NC, Dryden, M, Kujath, P, Nathwani, D, Arvis, P, Reimnitz, P, Alder, J & Gyssens, IC 2013, 'Efficacy and safety of IV/PO moxifloxacin and IV piperacillin/tazobactam followed by PO amoxicillin/clavulanic acid in the treatment of diabetic foot infections: results of the RELIEF study', Infection, vol. 41, no. 1, pp. 175-186. https://doi.org/10.1007/s15010-012-0367-x

Efficacy and safety of IV/PO moxifloxacin and IV piperacillin/tazobactam followed by PO amoxicillin/clavulanic acid in the treatment of diabetic foot infections: results of the RELIEF study. / Schaper, N. C.; Dryden, M.; Kujath, P.; Nathwani, D.; Arvis, P.; Reimnitz, P.; Alder, J.; Gyssens, I. C.

In: Infection, Vol. 41, No. 1, 02.2013, p. 175-186.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Efficacy and safety of IV/PO moxifloxacin and IV piperacillin/tazobactam followed by PO amoxicillin/clavulanic acid in the treatment of diabetic foot infections: results of the RELIEF study

AU - Schaper, N. C.

AU - Dryden, M.

AU - Kujath, P.

AU - Nathwani, D.

AU - Arvis, P.

AU - Reimnitz, P.

AU - Alder, J.

AU - Gyssens, I. C.

PY - 2013/2

Y1 - 2013/2

KW - Antibiotic therapy

KW - Diabetic foot infection

KW - Fluoroquinolone

KW - Moxifloxacin

KW - Controlled clinical trial

KW - Sequential therapy

KW - Diabetic foot ulcer

U2 - 10.1007/s15010-012-0367-x

DO - 10.1007/s15010-012-0367-x

M3 - Article

C2 - 23180507

VL - 41

SP - 175

EP - 186

JO - Infection

JF - Infection

SN - 0300-8126

IS - 1

ER -